Filed: 7/28/2026ACC: 0001193125-26-318812
📋 What this filing means
SANOFI filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $534.04M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$534.04M
Total AUM (reported)
30.52M
Total Shares
Allocation by class
COM$365.78M68.5%
COM NEW$64.81M12.1%
COMMON STOCK$37.27M7.0%
SPONSORED ADS$36.12M6.8%
ORD SHS$16.54M3.1%
CLASS A COM$13.52M2.5%
Portfolio Concentration
Top 3$339.32M63.5%
4–10$194.72M36.5%
Top 3 weight
63.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 30.52M
Sole
Full voting authority
30.52M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
MeiraGTx Holdings plc
SOLEShares12.20M
TypeSH
Market value$164.79M
30.86%
Sole
12.20M
Shared
0.00
None
0.00
Inhibrx Biosciences, Inc.
SOLEShares1.16M
TypeSH
Market value$109.71M
20.54%
Sole
1.16M
Shared
0.00
None
0.00
Novavax
SOLEShares6.88M
TypeSH
Market value$64.81M
12.14%
Sole
6.88M
Shared
0.00
None
0.00
AnaptysBio
SOLEShares821.92K
TypeSH
Market value$55.48M
10.39%
Sole
821.92K
Shared
0.00
None
0.00
Odyssey Therapeutics Inc.
SOLEShares1.99M
TypeSH
Market value$37.27M
6.98%
Sole
1.99M
Shared
0.00
None
0.00
Agomab Therapeutics NV
SOLEShares2.78M
TypeSH
Market value$36.12M
6.76%
Sole
2.78M
Shared
0.00
None
0.00
MapLight Therapeutics Inc.
SOLEShares912.04K
TypeSH
Market value$32.69M
6.12%
Sole
912.04K
Shared
0.00
None
0.00
First Tracks Biotherapeutics Inc.
SOLEShares821.92K
TypeSH
Market value$16.54M
3.10%
Sole
821.92K
Shared
0.00
None
0.00
Immuneering Corp
SOLEShares2.71M
TypeSH
Market value$13.52M
2.53%
Sole
2.71M
Shared
0.00
None
0.00
Q32 Bio Inc.
SOLEShares244.08K
TypeSH
Market value$3.11M
0.58%
Sole
244.08K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MeiraGTx Holdings plcSOLE | COM | 12.20M | SH | $164.79M 30.86% | 12.20M | 0.00 | 0.00 |
Inhibrx Biosciences, Inc.SOLE | COM | 1.16M | SH | $109.71M 20.54% | 1.16M | 0.00 | 0.00 |
NovavaxSOLE | COM NEW | 6.88M | SH | $64.81M 12.14% | 6.88M | 0.00 | 0.00 |
AnaptysBioSOLE | COM | 821.92K | SH | $55.48M 10.39% | 821.92K | 0.00 | 0.00 |
Odyssey Therapeutics Inc.SOLE | COMMON STOCK | 1.99M | SH | $37.27M 6.98% | 1.99M | 0.00 | 0.00 |
Agomab Therapeutics NVSOLE | SPONSORED ADS | 2.78M | SH | $36.12M 6.76% | 2.78M | 0.00 | 0.00 |
MapLight Therapeutics Inc.SOLE | COM | 912.04K | SH | $32.69M 6.12% | 912.04K | 0.00 | 0.00 |
First Tracks Biotherapeutics Inc.SOLE | ORD SHS | 821.92K | SH | $16.54M 3.10% | 821.92K | 0.00 | 0.00 |
Immuneering CorpSOLE | CLASS A COM | 2.71M | SH | $13.52M 2.53% | 2.71M | 0.00 | 0.00 |
Q32 Bio Inc.SOLE | COM | 244.08K | SH | $3.11M 0.58% | 244.08K | 0.00 | 0.00 |